Clinical Trial Update: Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells [Phase 1]

View source ↗

Summary

Phase 1 study of autologous CAR-T cells targeting B7-H3 (iC9-CAR.B7-H3 T Cells) for triple-negative breast cancer; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• iC9-CAR.B7-H3 T Cells

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer, Relapse | Phase 1 | Status: RECRUITING